Furlanut M - Search Results

1

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Pea F, Viale P, Furlanut M. Pea F, et al. Among authors: furlanut m. Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.

2

Antimicrobial agents in elective surgery: prophylaxis or "early therapy"?

Pea F, Viale P, Furlanut MI. Pea F, et al. Among authors: furlanut mi. J Chemother. 2003 Feb;15(1):3-11. doi: 10.1179/joc.2003.15.Supplement-2.3. J Chemother. 2003. PMID: 12678408 Review.

3

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.

Pea F, Viale P, Pavan F, Furlanut M. Pea F, et al. Among authors: furlanut m. Clin Pharmacokinet. 2007;46(12):997-1038. doi: 10.2165/00003088-200746120-00003. Clin Pharmacokinet. 2007. PMID: 18027987 Review.

4

Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.

Pea F, Pavan F, Furlanut M. Pea F, et al. Among authors: furlanut m. Clin Pharmacokinet. 2008;47(7):449-62. doi: 10.2165/00003088-200847070-00002. Clin Pharmacokinet. 2008. PMID: 18563954 Review.

5

Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.

Pea F, Furlanut M, Negri C, Pavan F, Crapis M, Cristini F, Viale P. Pea F, et al. Among authors: furlanut m. Antimicrob Agents Chemother. 2009 May;53(5):1863-7. doi: 10.1128/AAC.01149-08. Epub 2009 Feb 17. Antimicrob Agents Chemother. 2009. PMID: 19223642 Free PMC article.

6

Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Pea F, Viale P, Cojutti P, Furlanut M. Pea F, et al. Among authors: furlanut m. Antimicrob Agents Chemother. 2012 Dec;56(12):6343-8. doi: 10.1128/AAC.01291-12. Epub 2012 Oct 8. Antimicrob Agents Chemother. 2012. PMID: 23045356 Free PMC article.

7

TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients.

Pea F, Bertolissi M, Di Silvestre A, Poz D, Giordano F, Furlanut M. Pea F, et al. Among authors: furlanut m. Int J Antimicrob Agents. 2002 Nov;20(5):326-32. doi: 10.1016/s0924-8579(02)00188-7. Int J Antimicrob Agents. 2002. PMID: 12431867 Clinical Trial.

8

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.

Pea F, Brollo L, Viale P, Pavan F, Furlanut M. Pea F, et al. Among authors: furlanut m. J Antimicrob Chemother. 2003 Apr;51(4):971-5. doi: 10.1093/jac/dkg147. Epub 2003 Feb 25. J Antimicrob Chemother. 2003. PMID: 12654757

9

MEGX disposition in critically-ill trauma patients: subsequent assessments during the first week following trauma.

Pea F, Licari M, Baldassarre M, Furlanut M. Pea F, et al. Among authors: furlanut m. Fundam Clin Pharmacol. 2002 Dec;16(6):519-25. doi: 10.1046/j.1472-8206.2002.00108.x. Fundam Clin Pharmacol. 2002. PMID: 12685511

10

Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.

Pea F, Di Qual E, Cusenza A, Brollo L, Baldassarre M, Furlanut M. Pea F, et al. Among authors: furlanut m. Clin Pharmacokinet. 2003;42(6):589-98. doi: 10.2165/00003088-200342060-00008. Clin Pharmacokinet. 2003. PMID: 12793843 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters